Accuracy of lipid profiles in the hospital setting: Impact on the initiation of cholesterol-lowering therapy

被引:0
|
作者
Keilson, L
机构
来源
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Hospitalization for an acute ec ent. such as myocardial infarction. is an opportune time for screening lipids, counseling patients, and advising them about treatments. Physicians frequently fail to seize these "windows of opportunity" that hospitalization presents. The hospital setting may be the best time to screen a patient's lipid levels and systems can be set up to accomplish this in a timely fashion. There are certain illnesses, procedures, and conditions under which a patient's lipids may be altered and these should be considered ui hcn about to undertake screening. The conventional Freidewald test appears to be as reliable as newer lipid-screening measures. Using this test, nonfasting lipids can reliably predict patients with elevated cholesterol.
引用
收藏
页码:S18 / S20
页数:3
相关论文
共 50 条
  • [1] LINKING CELLULAR LIPID TRAFFICKING PROFILES OF INDIVIDUALS TO THE OUTCOMES OF CHOLESTEROL-LOWERING THERAPY IN THE GENERAL POPULATION
    Hlushchenko, I.
    Islam, M. M.
    Tamlander, M.
    Ripatti, S.
    Pfisterer, S.
    ATHEROSCLEROSIS, 2023, 379
  • [2] Cholesterol-lowering therapy - Response
    Matsuoka, H
    Tamai, O
    Imaizumi, T
    CIRCULATION, 1997, 96 (10) : 3801 - 3802
  • [3] Cholesterol-lowering therapy for smokers
    Jackson, PR
    LANCET, 2001, 357 (9260): : 960 - 960
  • [4] Pharmacogenomics of cholesterol-lowering therapy
    Schmitz, G
    Langmann, T
    VASCULAR PHARMACOLOGY, 2006, 44 (02) : 75 - 89
  • [5] LINKING CELLULAR LIPID METABOLISM PROFILES TO THE OUTCOMES OF CHOLESTEROL-LOWERING THERAPY IN A GENERAL POPULATION COHORT STUDY
    Hlushchenko, I.
    Islam, M. M.
    Pfisterer, S.
    ATHEROSCLEROSIS, 2022, 355 : E41 - E42
  • [6] Appropriate use of cholesterol-lowering therapy
    Falk, Erling
    ATHEROSCLEROSIS, 2017, 262 : 198 - 199
  • [7] Need to individualise cholesterol-lowering therapy
    Luetjohann, Dieter
    Weingaertner, Oliver
    HEART, 2019, 105 (16)
  • [8] The future direction of cholesterol-lowering therapy
    Evans, M
    Roberts, A
    Rees, A
    CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (06) : 663 - 669
  • [9] Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy
    Schmitz, Gerd
    Schmitz-Madry, Anna
    Ugocsai, Peter
    CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (02) : 164 - 173
  • [10] Cholesterol-lowering therapy: Is there really a controversy?
    Jungnickel, PW
    ANNALS OF PHARMACOTHERAPY, 1996, 30 (05) : 539 - 542